Your browser doesn't support javascript.
loading
CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy.
Lende, Stine Sofie Frank; Pahus, Marie Høst; Monrad, Ida; Olesen, Rikke; Mahr, Anna R; Vibholm, Line K; Østergaard, Lars; Søgaard, Ole Schmeltz; Andersen, Anna Halling Folkmar; Denton, Paul W; Tolstrup, Martin.
Afiliación
  • Lende SSF; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Pahus MH; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Monrad I; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Olesen R; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Mahr AR; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
  • Vibholm LK; Department of Biology, University of Nebraska at Omaha, Omaha, NE, United States.
  • Østergaard L; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Søgaard OS; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
  • Andersen AHF; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Denton PW; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
  • Tolstrup M; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Front Cell Infect Microbiol ; 12: 919097, 2022.
Article en En | MEDLINE | ID: mdl-35865810

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptor Toll-Like 9 / Lectina 1 Similar a Ig de Unión al Ácido Siálico Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptor Toll-Like 9 / Lectina 1 Similar a Ig de Unión al Ácido Siálico Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article